Source:http://linkedlifedata.com/resource/pubmed/id/11089576
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2000-12-7
|
pubmed:abstractText |
The mechanisms leading to the abnormal self-polymerization of tau into straight and paired helical filaments (PHFs) and neurofibrillary tangles (NFT) in Alzheimer disease (AD) and progressive supranuclear palsy (PSP) are not known. However, transglutaminase-induced cross-linking of PHF-tau was observed in AD and thus may also contribute to the formation of NFT in other neurodegenerative disorders including PSP. Tissue homogenates from PSP and normal age-matched controls were used to immunoaffinity-purify proteins containing transglutaminase-induced epsilon-(gamma-glutamyl) lysine cross-links. The immunoaffinity-purified proteins were then examined on immunoblots with a PHF-tau antibody, PHF-1. There were significantly higher levels of epsilon-(gamma-glutamyl) lysine cross-linking of PHF-tau in globus pallidus and pons regions of PSP cases compared to barely detectable cross-links in controls. The occipital cortex, an area spared from neurofibrillary pathology in PSP, showed no detectable cross-linking of PHF-tau protein in either PSP cases or control cases. Double-label immunofluorescence demonstrated the colocalization of the cross-link and PHF-tau in NFT in pons of PSP Previous studies and present data are consistent with the hypothesis that transglutaminase-induced cross-linking may be a factor contributing to the abnormal polymerization and stabilization of tau in straight and PHFs leading to neurofibrillary tangle formation in neurodegenerative diseases, including PSP and AD.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0022-3069
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
59
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
983-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11089576-Aged,
pubmed-meshheading:11089576-Alzheimer Disease,
pubmed-meshheading:11089576-Cross-Linking Reagents,
pubmed-meshheading:11089576-Globus Pallidus,
pubmed-meshheading:11089576-Humans,
pubmed-meshheading:11089576-Neurofibrillary Tangles,
pubmed-meshheading:11089576-Occipital Lobe,
pubmed-meshheading:11089576-Pons,
pubmed-meshheading:11089576-Supranuclear Palsy, Progressive,
pubmed-meshheading:11089576-Transglutaminases,
pubmed-meshheading:11089576-tau Proteins
|
pubmed:year |
2000
|
pubmed:articleTitle |
Transglutaminase-induced cross-linking of tau proteins in progressive supranuclear palsy.
|
pubmed:affiliation |
Department of Pharmacology, Loyola University Chicago Medical Center, Maywood, Illinois 60153, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|